![Frontiers | Maternal and Fetal Outcomes After Interferon Exposure During Pregnancy: A Systematic Review With Meta-Analysis Frontiers | Maternal and Fetal Outcomes After Interferon Exposure During Pregnancy: A Systematic Review With Meta-Analysis](https://www.frontiersin.org/files/Articles/702929/frph-03-702929-HTML/image_m/frph-03-702929-g001.jpg)
Frontiers | Maternal and Fetal Outcomes After Interferon Exposure During Pregnancy: A Systematic Review With Meta-Analysis
![Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial - The Lancet Neurology Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial - The Lancet Neurology](https://www.thelancet.com/cms/attachment/2000992161/2003663757/gr1.gif)
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial - The Lancet Neurology
![Depressive symptoms as a side effect of Interferon-α therapy induced by induction of indoleamine 2,3-dioxygenase 1 | Scientific Reports Depressive symptoms as a side effect of Interferon-α therapy induced by induction of indoleamine 2,3-dioxygenase 1 | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep29920/MediaObjects/41598_2016_Article_BFsrep29920_Fig1_HTML.jpg)
Depressive symptoms as a side effect of Interferon-α therapy induced by induction of indoleamine 2,3-dioxygenase 1 | Scientific Reports
Qualitative Differences Between the IFNα subtypes and IFNβ Influence Chronic Mucosal HIV-1 Pathogenesis | PLOS Pathogens
![Predictors of response to pegylated interferon in chronic hepatitis B: a real-world hospital-based analysis | Scientific Reports Predictors of response to pegylated interferon in chronic hepatitis B: a real-world hospital-based analysis | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep29605/MediaObjects/41598_2016_Article_BFsrep29605_Fig1_HTML.jpg)
Predictors of response to pegylated interferon in chronic hepatitis B: a real-world hospital-based analysis | Scientific Reports
![Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial - The Lancet Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/2119418385/2093586859/gr1.gif)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial - The Lancet
![Type I interferon signaling, regulation and gene stimulation in chronic virus infection - ScienceDirect Type I interferon signaling, regulation and gene stimulation in chronic virus infection - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1044532319300387-gr2.jpg)
Type I interferon signaling, regulation and gene stimulation in chronic virus infection - ScienceDirect
![Interferon therapy for COVID-19 and emerging infections: Prospects and concerns | Cleveland Clinic Journal of Medicine Interferon therapy for COVID-19 and emerging infections: Prospects and concerns | Cleveland Clinic Journal of Medicine](https://www.ccjm.org/content/ccjom/early/2020/12/01/ccjm.87a.ccc066/F1.large.jpg)
Interferon therapy for COVID-19 and emerging infections: Prospects and concerns | Cleveland Clinic Journal of Medicine
![A Critical Risk Factor for a Major Side Effect of Interferon-Alpha Therapy: Activated Indoleamine 2,3-Dioxygenase 1 is Related to Depressive Symptoms | IntechOpen A Critical Risk Factor for a Major Side Effect of Interferon-Alpha Therapy: Activated Indoleamine 2,3-Dioxygenase 1 is Related to Depressive Symptoms | IntechOpen](https://cdn.intechopen.com/books/images_new/6192.jpg)
A Critical Risk Factor for a Major Side Effect of Interferon-Alpha Therapy: Activated Indoleamine 2,3-Dioxygenase 1 is Related to Depressive Symptoms | IntechOpen
![A Critical Risk Factor for a Major Side Effect of Interferon-Alpha Therapy: Activated Indoleamine 2,3-Dioxygenase 1 is Related to Depressive Symptoms | IntechOpen A Critical Risk Factor for a Major Side Effect of Interferon-Alpha Therapy: Activated Indoleamine 2,3-Dioxygenase 1 is Related to Depressive Symptoms | IntechOpen](https://www.intechopen.com/media/chapter/57164/media/F3.png)